Table 1. Demographics of the Markey Cancer Center population.
| Patient Demographics | |
|---|---|
| Age | 62.14 ± 10.79 |
| BMI | 36.38 ± 10.22 |
| Race | |
| Caucasian | 59 (90.8%) |
| African American | 5 (7.7%) |
| Asian | 1 (1.5%) |
| Grade | |
| 1 | 20 (30.7%) |
| 2 | 12 (18.5%) |
| 3 | 33 (50.8%) |
| Clinical stage | |
| I | 31 (47.7%) |
| II | 5 (7.7%) |
| III | 14 (21.5%) |
| IV | 12 (18.5%) |
| Unknown | 3 (4.6%) |
| Clinical stage, early vs. late | |
| Early stage (I-II) | 36 (55.4%) |
| Late stage (III-IV) | 26 (40.0%) |
| Unknown | 3 (4.6%) |
| Tobacco use (smoking) | |
| No | 43 (66.2%) |
| Yes | 21 (32.3%) |
| Unknown | 1 (1.5%) |
| Documented recurrence | |
| No | 42 (64.6%) |
| Yes | 16 (24.6%) |
| Unknown | 7 (10.8%) |
| Appalachian status | |
| Non-Appalachian | 25 (38.5%) |
| Appalachian | 40 (61.5%) |
| Histologic subtype | |
| Endometrioid | 37 (57.0%) |
| Mixed cell adenocarcinoma | 5 (7.7%) |
| Carcinosarcoma | 6 (9.2%) |
| Serous | 15 (23.1%) |
| Other: Clear cell, malignant mesonephroma | 2 (3.1%) |
| DACH1 | |
| Mutated | 12 (18.5%) |
| Wild-type | 53 (81.5%) |